(1) The Opioid Reversal Medication and Harm Reduction Clearinghouse Bulk Purchasing Fund is established in the State Treasury, separate and distinct from the General Fund. Interest earned by the Opioid Reversal Medication and Harm Reduction Clearinghouse Bulk Purchasing Fund shall be credited to the fund.
(2) The Opioid Reversal Medication and Harm Reduction Clearinghouse Bulk Purchasing Fund consists of:
(a) Moneys received by the Oregon Health Authority from opioid litigation settlements;
(b) Grants awarded for the purpose of addressing substance use and overdose epidemics;
(c) Other gifts, grants, bequests, endowments or donations made to the fund; and
(d) Moneys appropriated to the fund by the Legislative Assembly.
(3) The moneys in the Opioid Reversal Medication and Harm Reduction Clearinghouse Bulk Purchasing Fund are continuously appropriated to the Oregon Health Authority for expenses related to opioid harm reduction.